AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $1.01B
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.54M
Average 1.38M
AHCO Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
AdaptHealth Corp.NASDAQ: AHCO
Selling, General & Admin · Q1 FY2026 · quarter ended Apr 2026
Selling, general & admin growth accelerates
Q1 FY2026 selling, general & admin of $95.91M rose 10.4% year over year, ahead of the -14.8% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 11.1% from the prior quarter. Over 3 fiscal years it compounded at +33.1% a year.
Context
- Selling, general & admin amounted to 11.8% of revenue in FY2025, up 0.8 pp from a year earlier.
- Selling, general & admin increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 5 analysts of $238.4M (-37.6%) for the fiscal year ending Dec 2026, a slowdown from the +6.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $95.91M-11.1% QoQ
- Last fiscal yearDec 2025
- $382.29M+6.4% YoY
- LTMApr 2026
- $385.95M-14.8% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 382.29M USD
- Year-over-year change
- +6.4%
- 4-year CAGR
- +22.9%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 382.29M | +6.4% |
| FY2024 | 2024-12-31 | 359.24M | +89.0% |
| FY2023 | 2023-12-31 | 190.09M | +17.2% |
| FY2022 | 2022-12-31 | 162.13M | -3.2% |
| FY2021 | 2021-12-31 | 167.51M | — |
Selling, General & Admin vs competitors
How AHCO compares with its peers on the latest reported figures
- AHCO's LTM Apr 2026 selling, general & admin of $385.95M is the 4th highest of the 9 companies compared; the peer median is $150.84M.
- Its year-over-year change of -14.8% is the lowest of 9, against a peer median of +9.0%.
- Selling, general & admin amounts to 13.5% of revenue for AHCO, versus a peer median of 47.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.11B | +12.4% | +8.6% | 19.7% | |
| LTM Jun 2026 | $620.31M | +7.7% | +24.9% | 69.0% | |
| LTM Mar 2026 | $437.36M | +5.8% | +9.0% | 42.6% | |
| LTM Apr 2026 | $385.95M | -14.8% | +33.1% | 13.5% | |
| LTM Mar 2026 | $167.18M | -2.6% | +0.1% | 47.6% | |
| LTM Mar 2026 | $134.5M | +15.0% | +21.2% | 46.9% | |
| LTM Mar 2026 | $102.76M | +61.1% | +40.3% | 93.2% | |
| LTM Mar 2026 | $67.04M | +5.2% | +6.1% | 47.1% | |
| LTM Mar 2026 | $41.69M | +10.2% | +13.0% | 58.1% | |
| Peer median (excluding AHCO) | $150.84M | +9.0% | +11.0% | 47.3% | |
Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.45B | 2.97B | 3.2B | 3.26B | 3.24B |
| Cost of Revenue | 2.01B | 2.55B | 2.52B | 2.58B | 2.68B |
| Gross Profit | 445.61M | 417.43M | 681.77M | 681.09M | 568.56M |
| Gross Margin | 18.2% | 14.1% | 21.3% | 20.9% | 17.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 167.51M | 162.13M | 190.09M | 359.24M | 382.29M |
| Operating Expenses | 220.01M | 227.02M | 1.28B | 417.36M | 382.29M |
| Depreciation & Amortization | 258.05M | 423.44M | 420.59M | 365.33M | 413.04M |
| EBITDA | 544.21M | 630.76M | (171.09M) | 628.02M | 503.64M |
| EBITDA Margin | 22.2% | 21.2% | -5.3% | 19.3% | 15.5% |
| Operating Income | 225.61M | 190.41M | (598.4M) | 263.73M | 186.27M |
| Operating Margin | 9.2% | 6.4% | -18.7% | 8.1% | 5.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 95.2M | 109.41M | 130.3M | 126.67M | 105.75M |
| Other Income / Expenses | (34.65M) | (92.51M) | (125.38M) | (127.71M) | (201.42M) |
| Income Before Tax | 190.96M | 97.9M | (723.78M) | 136.02M | (15.15M) |
| Pre-Tax Margin | 7.8% | 3.3% | -22.6% | 4.2% | -0.5% |
| Income Tax Expense | 32.81M | 24.77M | (49M) | 41.24M | 50.88M |
| Net Income | 156.18M | 69.32M | (678.9M) | 90.42M | (70.79M) |
| Net Margin | 6.4% | 2.3% | -21.2% | 2.8% | -2.2% |
| EPS (Basic) | 1.12 | 0.52 | (5.32) | 0.62 | (0.52) |
| EPS (Diluted) | 0.67 | 0.50 | (5.31) | 0.61 | (0.52) |
| Weighted Avg Shares | 126.31M | 134.18M | 134.16M | 133.76M | 135.15M |
| Weighted Avg Shares (Diluted) | 133.03M | 138.99M | 134.42M | 135.53M | 135.15M |
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.